Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies.
作者信息
Martín-Moro Fernando, Marquet Juan, Piris Miguel, Michael Berta M, Sáez Adolfo J, Corona Magdalena, Jiménez Carlos, Astibia Beatriz, García Irene, Rodríguez Eulalia, García-Hoz Carlota, Fortún-Abete Jesús, Herrera Pilar, López-Jiménez Javier
机构信息
Department of Haematology, Ramón y Cajal University Hospital, Madrid, Spain.
Department of Immunology, Ramón y Cajal University Hospital, Madrid, Spain.
出版信息
Br J Haematol. 2020 Jul;190(1):e16-e20. doi: 10.1111/bjh.16801. Epub 2020 May 27.
Abstract
摘要
相似文献
1
Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies.
Br J Haematol. 2020 Jul;190(1):e16-e20. doi: 10.1111/bjh.16801. Epub 2020 May 27.
2
Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience.
Br J Haematol. 2020 Sep;190(5):e279-e282. doi: 10.1111/bjh.16935. Epub 2020 Aug 10.
3
COVID-19 and QT interval prolongation: more than just drug toxicity?
Europace. 2020 Oct 1;22(10):1479. doi: 10.1093/europace/euaa145.
4
Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019.
Allergy Asthma Proc. 2020 Nov 1;41(6):e80-e82. doi: 10.2500/aap.2020.41.200079.
5
Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.
Trials. 2020 Jul 8;21(1):631. doi: 10.1186/s13063-020-04566-x.
6
Cardiac Troponin I Is an Independent Predictor for Mortality in Hospitalized Patients With COVID-19.
Circulation. 2020 Aug 11;142(6):608-610. doi: 10.1161/CIRCULATIONAHA.120.048789. Epub 2020 Jun 15.
7
Two consecutive myocardial tissue insults for inpatients with COVID-19.
Crit Care. 2020 May 26;24(1):259. doi: 10.1186/s13054-020-02981-9.
8
COVID-19 in pediatric hematopoietic stem cell transplantation: The experience of Spanish Group of Transplant (GETMON/GETH).
Pediatr Blood Cancer. 2020 Sep;67(9):e28514. doi: 10.1002/pbc.28514. Epub 2020 Jun 23.
9
Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report.
J Antimicrob Chemother. 2020 Sep 1;75(9):2706-2707. doi: 10.1093/jac/dkaa213.
10
COVID-19 infection in patients with sickle cell disease.
Br J Haematol. 2020 Jun;189(5):851-852. doi: 10.1111/bjh.16734. Epub 2020 May 8.
引用本文的文献
1
Factors Associated With Mortality in Leukemia and Lymphoma With COVID-19: A National Inpatient Sample Analysis (2020-2021).
Cureus. 2025 Jun 22;17(6):e86534. doi: 10.7759/cureus.86534. eCollection 2025 Jun.
2
Early combined therapy for COVID-19 in immunocompromised patients: a promising approach against viral persistence and drug resistance.
BMC Infect Dis. 2025 Apr 28;25(1):616. doi: 10.1186/s12879-025-11012-3.
3
Efficacy of Ayurvedic treatment given to cancer patients in the prevention of COVID-19 - A Retrospective Cohort Study at Integrated Cancer Treatment and Research Centre, Wagholi.
J Ayurveda Integr Med. 2025 Mar 5;16(2):101045. doi: 10.1016/j.jaim.2024.101045.
4
Clinical characteristics of SARS-CoV-2 Omicron pneumonia in immunocompromised and immunocompetent patients: A retrospective cohort study.
Heliyon. 2024 Oct 9;10(20):e39044. doi: 10.1016/j.heliyon.2024.e39044. eCollection 2024 Oct 30.
5
Identifying risk factors for severe omicron infection in allogeneic hematopoietic stem cell transplant recipients with hematologic malignancies.
Cancer Rep (Hoboken). 2024 Jun;7(6):e2103. doi: 10.1002/cnr2.2103.
6
Assessing the impact of COVID-19 on acute leukemia patients: a comparative analysis of hematological and biochemical parameters.
BMC Infect Dis. 2024 Jun 11;24(1):576. doi: 10.1186/s12879-024-09485-9.
7
Characteristics and prognosis of patients with COVID-19 and hematological diseases in Japan: a cross-sectional study.
Int J Hematol. 2024 Feb;119(2):183-195. doi: 10.1007/s12185-023-03685-w. Epub 2024 Jan 3.
8
Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges.
Curr Obes Rep. 2024 Mar;13(1):1-34. doi: 10.1007/s13679-023-00542-z. Epub 2023 Dec 30.
9
Single-center study of outcomes of patients with hairy cell leukemia who contracted SARS-CoV-2.
EJHaem. 2023 Aug 31;4(4):1200-1202. doi: 10.1002/jha2.764. eCollection 2023 Nov.
10
Recurrent COVID-19 Infection in a Refractory/Classical Hodgkin's Lymphoma Patient Undergoing Autologous Stem Cell Transplantation: A Case Report.
Cureus. 2023 Oct 13;15(10):e46950. doi: 10.7759/cureus.46950. eCollection 2023 Oct.
本文引用的文献
1
COVID-19 in persons with haematological cancers.
Leukemia. 2020 Jun;34(6):1637-1645. doi: 10.1038/s41375-020-0836-7. Epub 2020 Apr 24.
2
COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis.
JCO Glob Oncol. 2020 Apr;6:557-559. doi: 10.1200/GO.20.00097.
3
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.
Int J Antimicrob Agents. 2020 May;55(5):105954. doi: 10.1016/j.ijantimicag.2020.105954. Epub 2020 Mar 29.
4
Care of haematology patients in a COVID-19 epidemic.
Br J Haematol. 2020 Apr;189(2):241-243. doi: 10.1111/bjh.16620. Epub 2020 Mar 15.
5
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
6
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
Zotero 插件